Boeing Company (The) vs Xylem Inc. — Stock Comparison
Q·Score Breakdown
6.2
Neutral
Overall
7.5
Bullish
Quality
Health
Growth
Valuation
Sentiment
BA
78% of 27 covering analysts have a positive rating.
⚠ high leverage at 8.3× debt-to-equity.
XYL
Consensus analyst target of $150.82 is 31% above current price.
Analyst Consensus
BUY
Target $269.52 (+18.5%)
25 analysts
BUY
Target $150.82 (+30.7%)
17 analysts
Fundamentals
BA
XYL
90.2×
Trailing P/E
28.8×
53.0×
Forward P/E
19.0×
2.5%
Profit Margin
10.8%
4.8%
Gross Margin
38.6%
169.9%
ROE
8.7%
14.0%
Revenue Growth
2.7%
—
Earnings Growth
14.5%
1.13
Beta
1.17
—
Price / Book
—
$179.2B
Market Cap
$27.4B
$177 – $254
52-Week Range
$114 – $154
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →